Post-Trade Analysis: Codexis Inc. (CDXS) Climbs 1.45, Closing at 2.80

The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.

After finishing at $2.76 in the prior trading day, Codexis Inc. (NASDAQ: CDXS) closed at $2.80, up 1.45%. In other words, the price has increased by $1.45 from its previous closing price. On the day, 0.62 million shares were traded. CDXS stock price reached its highest trading level at $2.895 during the session, while it also had its lowest trading level at $2.71.

Ratios:

Our goal is to gain a better understanding of CDXS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.53 and its Current Ratio is at 2.61. In the meantime, Its Debt-to-Equity ratio is 0.26 whereas as Long-Term Debt/Eq ratio is at 0.14.

TD Cowen Downgraded its Outperform to Market Perform on August 07, 2023, whereas the target price for the stock was revised from $21 to $4.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 15 ’23 when Dorgan Byron L sold 20,000 shares for $2.11 per share. The transaction valued at 42,168 led to the insider holds 193,461 shares of the business.

Norrett Kevin bought 9,000 shares of CDXS for $15,479 on Sep 11 ’23. The Chief Operating Officer now owns 98,102 shares after completing the transaction at $1.72 per share. On Sep 08 ’23, another insider, DILLY STEPHEN GEORGE, who serves as the insider of the company, bought 58,479 shares for $1.73 each. As a result, the insider paid 100,952 and bolstered with 438,878 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDXS now has a Market Capitalization of 196850080 and an Enterprise Value of 147758192. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.81 while its Price-to-Book (P/B) ratio in mrq is 2.26. Its current Enterprise Value per Revenue stands at 2.107 whereas that against EBITDA is -2.998.

Stock Price History:

Over the past 52 weeks, CDXS has reached a high of $4.91, while it has fallen to a 52-week low of $1.45. The 50-Day Moving Average of the stock is -15.40%, while the 200-Day Moving Average is calculated to be 8.71%.

Shares Statistics:

The stock has traded on average 584.54K shares per day over the past 3-months and 372980 shares per day over the last 10 days, according to various share statistics. A total of 69.91M shares are outstanding, with a floating share count of 67.27M. Insiders hold about 4.31% of the company’s shares, while institutions hold 79.68% stake in the company. Shares short for CDXS as of 1711584000 were 2383322 with a Short Ratio of 4.08, compared to 1709164800 on 2544036. Therefore, it implies a Short% of Shares Outstanding of 2383322 and a Short% of Float of 3.46.

Earnings Estimates

Codexis Inc. (CDXS) is currently under the scrutiny of Cadence Design Systems, Inc. analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is $3.79, with high estimates of $0.57 and low estimates of $2.80.

Analysts are recommending an EPS of between $Healthcare and $Healthcare for the fiscal current year, implying an average EPS of $Healthcare.

Most Popular

[the_ad id="945"]